Really encouraging to see the UK and @euda.europa.eu sign a Working Arrangement today. Faster, reciprocal information-sharing on emerging substances and drug threats is exactly the kind of evidence-based, cross-border cooperation that helps protect public health and reduce harm.
Alex Piot
@alexpiot.bsky.social
PhD student at the Clinical Psychopharmacology Unit - UCL | Wellcome Trust Director of Research - Centre for Evidence Based Drug Policy
@matsouthwell.bsky.social and the Ketamine - Peer Advisory Group (K-PAG) are working hard to provide peer education and promote harm reduction at Beat Herder Fest. for people with k-cramps and ketamine bladder syndrome. Consider donating or sharing this to help fund their work. gofund.me/ddf7d6050
Donate to K-PAG festival intervention at Beat Herder, organized by Mat Southwell
My name is Mat Southwell. I am helping a team of peer workers from the Ketami… Mat Southwell needs your support for K-PAG festival intervention at Beat Herder
gofund.me
New website I made for our lab is live, come have a look at what the Clinical Psychopharmacology Unit is up to 🙂 Built with a lot of AI help on the coding side. cpu-lab.org
CPU — Clinical Psychopharmacology Unit
UCL's Clinical Psychopharmacology Unit studies how psychoactive drugs — psychedelics, dissociatives, cannabinoids and MDMA — act on the mind. We run clinical trials and laboratory studies to build evi...
cpu-lab.org
Only 26 countries have safer inhalation programmes. In the UK, s9A MDA 1971 still blocks pipe provision. The evidence is there. Policy needs to catch up. Our realist review in @ijdrugpolicy.bsky.social asks how, why & for whom does crack pipe provision work? www.sciencedirect.com/science/arti...
Provision of safer smoking equipment to reduce health harms and enhance service engagement among people who use crack: a realist informed review
Safer smoking equipment interventions for people who smoke crack cocaine have been unevenly implemented globally with most harm reduction policy and p…
sciencedirect.com
Filter mag reporting on the SIPP study, great to see this
“People would often start out with tin cans.” Research documents respiratory harms among people without access to safer pipes using homemade devices to smoke crack cocaine. Participants' feedback led to development of a better pipe, reports Sydney Sauer:
Coverage of our #PDDevaluation in @theguardian.com. Find out more at the National Symposium on Police-led Drug Diversion @sheffielduni.bsky.social this coming Thursday. www.theguardian.com/uk-news/2026...
Drug diversion schemes cut reoffending rates more than prosecution, study says
Exclusive: Research in England shows people a third less likely to reoffend under decriminalisation-style schemes
theguardian.com
I'm thrilled to share my first first-author paper 🎉 We review the synaptic correlates of benzodiazepine tolerance and the molecular mechanisms that drive it. Many thanks to Prof Jovanovic for all her support! 🔗 www.nature.com/articles/s41...
Synaptic correlates of benzodiazepine tolerance - Molecular Psychiatry
Molecular Psychiatry - Synaptic correlates of benzodiazepine tolerance
nature.com
"Pipes as an engagement tool: qualitative findings from a crack equipment and harm reduction training intervention in England" by Casey Sharpe and colleagues (2026) via @ijdrugpolicy.bsky.social . Does your area give out pipes for people who smoke drugs? Link: www.sciencedirect.com/science/arti...
We’re running a short survey on public views about ketamine reclassification and UK drug policy. If you’re 16+ and living in the UK, we’d really appreciate you taking 15 minutes to complete it and share with your networks: www.tinyurl.com/ket-survey
@charlotte2153.bsky.social speaking last night on record high drug-related deaths in the UK: “[The Home Office's stance] is ideological, not evidence-based, which is why I believe the Home Office is fundamentally incapable of dealing with drug deaths and drug harm in our communities.”
Great to see our commentary on stimulant use and nutrition hit the cover of Drink and Drug News magazine this month. Nutrition is often overlooked but crucial issue in harm reduction, time to bring it to the table ! viewer.joomag.com/ddn-october2...
DDN_October25 DDN October 2025
We have thought-provoking contributions on wellbeing in this issue – mental and physical – including our cover story (p6) in which the team demonstrate that addressing nutritional deficiency should be...
viewer.joomag.com
The landscape of ketamine use disorder: Patient experiences and perspectives on current treatment options buff.ly/HXPQOvF @bexharding.bsky.social
Our Op-ed on the UK’s drug death crisis, following last week’s Westminster Hall debate we helped secure. Drug-related deaths are a health issue—and should be governed by DHSC. The MDA in its current form is outdated and counterproductive. parliamentnews.co.uk/the-uks-drug...
New @ukparliament.parliament.uk report just released. Our Directors of Research @alexpiot.bsky.social & Psychedelic Policy & Regulation Timmy Davis were pleased to contribute, alongside @profdavidnutt.bsky.social, @profjoneill.bsky.social and others. post.parliament.uk/research-bri...
Psychedelic-assisted therapy for mental health: Policy considerations
Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.
post.parliament.uk
The #drugpolicyratchet looks set for another turn, even though the ACMD has repeatedly found no evidence that changing the class of a drug has any effect on levels of use. www.theguardian.com/society/2025... #ketamine
Home Office may reclassify ketamine in response to record levels of use
Illegal use in UK seems to reflect growth of unregulated market in US, where its high-profile users include Elon Musk
theguardian.com
Powerful closing #EHRC2024 plenary. Now the time for "strong language" to achieve, maintain & build #harmreduction with/for our communities. "No more hiding behind rhetoric of 'target' & 'vulnerable' populations". "Zero tolerance on poverty, zero tolerance on inequality, zero tolerance on stigma!"
A Private Member’s Bill proposing changes to how Schedule 2 drugs are amended is set for its second reading this Friday, with the full text now available. This could have significant implications—here’s why it matters… 👇 publications.parliament.uk/pa/bills/cbi...
publications.parliament.uk